Research graph
References from The gut speaks to the lung: Fecal microbiota and survival in idiopathic pulmonary fibrosis. Local targets link to admitted publications; unresolved targets remain external evidence.
The human intestinal microbiome in health and disease
10.1056/nejmra1600266 · 2016 · External reference
Airway microbiota is associated with upregulation of the PI3K pathway in lung cancer
10.1164/rccm.201710-2118oc · 2018 · External reference
Lower airway dysbiosis affects lung cancer progression
10.1158/2159-8290.cd-20-0263 · 2021 · External reference
Lower airway dysbiosis augments lung inflammatory injury in mild-to-moderate chronic obstructive pulmonary disease
10.1164/rccm.202210-1865oc · 2023 · External reference
Lung microbiota contribute to pulmonary inflammation and disease progression in pulmonary fibrosis
10.1164/rccm.201809-1650oc · 2019 · External reference
Commensal oral microbiota, disease severity, and mortality in fibrotic lung disease
10.1164/rccm.202308-1357oc · 2024 · External reference
The role of bacteria in the pathogenesis and progression of idiopathic pulmonary fibrosis
10.1164/rccm.201403-0541oc · 2014 · External reference
Functional lower airways genomic profiling of the microbiome to capture active microbial metabolism
10.1183/13993003.03434-2020 · 2021 · External reference
Effect of co-trimoxazole (trimethoprim-sulfamethoxazole) vs placebo on death, lung transplant, or hospital admission in patients with moderate and severe idiopathic pulmonary fibrosis: the EME-TIPAC randomized clinical trial
10.1001/jama.2020.22960 · 2020 · External reference
Effect of antimicrobial therapy on respiratory hospitalization or death in adults with idiopathic pulmonary fibrosis: the CleanUP-IPF randomized clinical trial
10.1001/jama.2021.4956 · 2021 · External reference
10.1093/ajrccm/aamag249 · 2026 · Admitted local publication
The gut microbiome is a significant risk factor for future chronic lung disease
10.1016/j.jaci.2022.12.810 · 2023 · External reference
